HRP20100212T1 - Pripravci s povećanim elastificirajućim učinkom - Google Patents
Pripravci s povećanim elastificirajućim učinkom Download PDFInfo
- Publication number
- HRP20100212T1 HRP20100212T1 HR20100212T HRP20100212T HRP20100212T1 HR P20100212 T1 HRP20100212 T1 HR P20100212T1 HR 20100212 T HR20100212 T HR 20100212T HR P20100212 T HRP20100212 T HR P20100212T HR P20100212 T1 HRP20100212 T1 HR P20100212T1
- Authority
- HR
- Croatia
- Prior art keywords
- use according
- component
- comes
- weight
- amount
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract 5
- 150000001875 compounds Chemical class 0.000 claims abstract 4
- 150000007524 organic acids Chemical class 0.000 claims abstract 4
- -1 organic acid ester Chemical class 0.000 claims abstract 3
- 210000002640 perineum Anatomy 0.000 claims abstract 2
- 230000000699 topical effect Effects 0.000 claims abstract 2
- 210000001215 vagina Anatomy 0.000 claims abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims 2
- JJVXHDTWVIPRBZ-VKHMYHEASA-N (2r)-2-[carboxy(methyl)amino]-3-sulfanylpropanoic acid Chemical compound OC(=O)N(C)[C@@H](CS)C(O)=O JJVXHDTWVIPRBZ-VKHMYHEASA-N 0.000 claims 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims 1
- 229930182558 Sterol Natural products 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 235000019568 aromas Nutrition 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 239000000850 decongestant Substances 0.000 claims 1
- 229940124581 decongestants Drugs 0.000 claims 1
- 239000000645 desinfectant Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229940016409 methylsulfonylmethane Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 235000002378 plant sterols Nutrition 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 235000003702 sterols Nutrition 0.000 claims 1
- 150000003432 sterols Chemical class 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- HHVIBTZHLRERCL-UHFFFAOYSA-N sulfonyldimethane Chemical compound CS(C)(=O)=O HHVIBTZHLRERCL-UHFFFAOYSA-N 0.000 claims 1
- 229960003080 taurine Drugs 0.000 claims 1
- DZLNHFMRPBPULJ-UHFFFAOYSA-N thioproline Chemical compound OC(=O)C1CSCN1 DZLNHFMRPBPULJ-UHFFFAOYSA-N 0.000 claims 1
- 229950001139 timonacic Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Reproductive Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Gynecology & Obstetrics (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
Upotreba: a) u najmanju ruku tioliranog spoja, ib) u najmanju ruku estera organske kiseline ili njihove smjese; naznačena time što su tiolorani spoj i organska kiselina namijenjeni proizvodnji topikalnog pripravka za poboljšavanje elastičnosti vagine i perineuma kod trudnica. Patent sadrži još 14 patentnih zahtjeva.
Claims (15)
1. Upotreba:
a) u najmanju ruku tioliranog spoja, i
b) u najmanju ruku estera organske kiseline ili njihove smjese;
naznačena time što su tiolorani spoj i organska kiselina namijenjeni proizvodnji topikalnog pripravka za poboljšavanje elastičnosti vagine i perineuma kod trudnica.
2. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što komponentu a) se bira između sulfatiranih aminokiselina i njihovih derivata.
3. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što komponentu a) se bira između 1-metionina, 1-cistein, 1-cistina, taurina, 4-tiazolidinkarboksilne kiseline, karboksimetilcisteina i/ili metilsulfonilmetana, ili njihovih fiziološki prihvatljivih soli.
4. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što komponenta a) dolazi u količini od 0,1 do 25 %, težinski.
5. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što komponentu a) dolazi u količini od 0,5 do 15 %, težinski.
6. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što komponentu a) dolazi u količini od 1,0 do 10 %, težinski.
7. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što komponenta b) je ester glicerola ili ester životinjskog ili biljnog sterol ili njihova smjesa.
8. Upotreba u skladu s patentnim zahtjevom 7, naznačena time što navedeni sterol je kolesterol.
9. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što navedena organska kiselina sadrži od 2 do 30 atoma ugljika, po mo gućnosti od 6 do 18 atoma ugljika, poželjnije od 12 do 18 atoma ugljika.
10. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što navedena organska kiselina je zasićena ili nezasićena.
11. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što komponenta b) dolazi u količini od 1,0 do 95 %, težinski.
12. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što komponenta b) dolazi u količini od 5 do 70 %, težinski.
13. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što komponenta b) dolazi u količini od 10 do 45 %, težinski.
14. Upotreba u skladu s patentnim zahtjevom 1, naznačena time što ulkjučuje jednu ili više farmaceutski prihvatljivih pomoćnih tvari.
15. Upotreba u skladu s patentnim zahtjevom 14, naznačena time što navedenu pomoćnu tvar se bira iz skupine koju čine: ionizacijska sredstva; antioksidansi; kelirajuća sredstva; ovlaživači; termoviskozirajuća sredstva; dekongestivi; dezinficijensi i/ili antimikrobna sredstva; arome i boje.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20060118649 EP1886676A1 (en) | 2006-08-09 | 2006-08-09 | Compositions with enhanced elasticizing activity |
| PCT/EP2007/053793 WO2008017521A2 (en) | 2006-08-09 | 2007-04-18 | Compositions with enhanced elasticizing activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20100212T1 true HRP20100212T1 (hr) | 2010-05-31 |
Family
ID=37575000
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20100212T HRP20100212T1 (hr) | 2006-08-09 | 2010-04-14 | Pripravci s povećanim elastificirajućim učinkom |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US9125806B2 (hr) |
| EP (2) | EP1886676A1 (hr) |
| JP (2) | JP2010500309A (hr) |
| KR (2) | KR101521166B1 (hr) |
| CN (1) | CN101500550B (hr) |
| AR (1) | AR062304A1 (hr) |
| AT (1) | ATE457723T1 (hr) |
| BR (1) | BRPI0715182C1 (hr) |
| CA (1) | CA2655472C (hr) |
| CY (1) | CY1110032T1 (hr) |
| DE (1) | DE602007004857D1 (hr) |
| DK (1) | DK2049092T3 (hr) |
| EA (1) | EA014971B1 (hr) |
| ES (1) | ES2340335T3 (hr) |
| HK (1) | HK1126956A1 (hr) |
| HR (1) | HRP20100212T1 (hr) |
| MX (1) | MX2009000869A (hr) |
| NO (1) | NO343143B1 (hr) |
| PL (1) | PL2049092T3 (hr) |
| PT (1) | PT2049092E (hr) |
| RS (1) | RS51282B (hr) |
| SI (1) | SI2049092T1 (hr) |
| WO (1) | WO2008017521A2 (hr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3081212A1 (en) | 2015-04-16 | 2016-10-19 | Polichem SA | Carboxymethylcysteine for topical treatment of stretch marks |
| EP3442501A1 (en) | 2016-04-15 | 2019-02-20 | Fairhaven Health, LLC | Compositions and methods for maintaining or enhancing homeostasis or function of female lower reproductive tract |
| IT202100002285A1 (it) * | 2021-02-03 | 2022-08-03 | Farm Dott Ferretti Stefano | Nuova composizione |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1617639A1 (de) * | 1966-09-12 | 1972-04-20 | Mini Ind Chimice | Verfahren zur Herstellung eines Arzneimittels zur Behandlung von physiologischen Hautkrankheiten |
| US4296130A (en) * | 1979-08-30 | 1981-10-20 | Herschler R J | Methylsulfonylmethane and methods of use |
| GB9213472D0 (en) * | 1992-06-25 | 1992-08-12 | Unilever Plc | Cosmetic composition |
| JPH10501817A (ja) * | 1994-06-15 | 1998-02-17 | ザ、プロクター、エンド、ギャンブル、カンパニー | 哺乳動物皮膚における色素過剰部位のライトニング方法 |
| JP3542665B2 (ja) * | 1995-07-07 | 2004-07-14 | 株式会社資生堂 | 抗老化皮膚外用剤、コラーゲン架橋阻害皮膚外用剤及び抗紫外線皮膚外用剤 |
| FR2740340B1 (fr) * | 1995-10-30 | 1997-12-05 | Oreal | Utilisation d'acides carboxyliques porteurs d'une fonction soufree pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique |
| US20040265268A1 (en) * | 2001-08-18 | 2004-12-30 | Deepak Jain | Compositions and methods for skin rejuvenation and repair |
| CH697081A5 (de) * | 2002-01-22 | 2008-04-30 | Andreas F Dr Schaub | Zusammensetzung für die Unterstützung der Geburt eines menschlichen Föten. |
| US6821524B2 (en) * | 2002-06-03 | 2004-11-23 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions |
| US20050266064A1 (en) * | 2004-05-29 | 2005-12-01 | Mccarthy Kathryn J | Cosmetic compositions and methods |
| US7087560B2 (en) | 2004-10-25 | 2006-08-08 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Personal care composition with salts of dihydroxypropyltri(C1-C3 alkyl) ammonium monosubstituted polyols |
| US20060088496A1 (en) | 2004-10-25 | 2006-04-27 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care compositions with salts of hydroxypropyl trialkylammonium substituted mono-saccharide |
| WO2006045584A1 (en) | 2004-10-25 | 2006-05-04 | Unilever Plc | Personal care compositions with glycerin and hydroxypropyl quaternary ammonium salts |
| DE102004054552A1 (de) * | 2004-11-11 | 2006-05-18 | Hcb Happy Child Birth Holding Ag | Neue Zusammensetzung zur Erleichterung der Humangeburt |
| US7351745B2 (en) * | 2004-12-22 | 2008-04-01 | Avon Products, Inc | Compositions and methods of their use for improving the condition and appearance of skin |
-
2006
- 2006-08-09 EP EP20060118649 patent/EP1886676A1/en not_active Withdrawn
-
2007
- 2007-04-18 DE DE200760004857 patent/DE602007004857D1/de active Active
- 2007-04-18 EA EA200900293A patent/EA014971B1/ru not_active IP Right Cessation
- 2007-04-18 US US12/310,032 patent/US9125806B2/en active Active
- 2007-04-18 KR KR1020147007704A patent/KR101521166B1/ko active IP Right Grant
- 2007-04-18 PT PT07728255T patent/PT2049092E/pt unknown
- 2007-04-18 DK DK07728255T patent/DK2049092T3/da active
- 2007-04-18 KR KR20097004495A patent/KR20090050065A/ko active Search and Examination
- 2007-04-18 RS RSP20100180 patent/RS51282B/sr unknown
- 2007-04-18 SI SI200730201T patent/SI2049092T1/sl unknown
- 2007-04-18 BR BRPI0715182A patent/BRPI0715182C1/pt active IP Right Grant
- 2007-04-18 CA CA 2655472 patent/CA2655472C/en active Active
- 2007-04-18 PL PL07728255T patent/PL2049092T3/pl unknown
- 2007-04-18 EP EP20070728255 patent/EP2049092B1/en active Active
- 2007-04-18 JP JP2009523211A patent/JP2010500309A/ja active Pending
- 2007-04-18 WO PCT/EP2007/053793 patent/WO2008017521A2/en active Application Filing
- 2007-04-18 ES ES07728255T patent/ES2340335T3/es active Active
- 2007-04-18 AT AT07728255T patent/ATE457723T1/de active
- 2007-04-18 CN CN2007800296579A patent/CN101500550B/zh active Active
- 2007-04-18 MX MX2009000869A patent/MX2009000869A/es active IP Right Grant
- 2007-08-09 AR ARP070103525 patent/AR062304A1/es not_active Application Discontinuation
-
2009
- 2009-03-06 NO NO20091011A patent/NO343143B1/no unknown
- 2009-05-19 HK HK09104533A patent/HK1126956A1/xx unknown
-
2010
- 2010-04-14 HR HR20100212T patent/HRP20100212T1/hr unknown
- 2010-05-14 CY CY101100418T patent/CY1110032T1/el unknown
-
2013
- 2013-07-08 JP JP2013142834A patent/JP5771649B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112012018384A2 (pt) | composição farmacêutica sólida com intensificadores e métodos de preparação da mesma. | |
| NZ731588A (en) | Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof | |
| PE20080331A1 (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
| NZ600231A (en) | Pharmaceutical compositions comprising sigma receptor ligands | |
| CL2015001975A1 (es) | (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos. | |
| RU2010123282A (ru) | Твердая лекарственная форма с быстрым высвобождением активного вещества, ее получение и применение | |
| MY148773A (en) | Galenic formulations of organic compounds | |
| MX340965B (es) | Combinaciones para el tratamiento de enfermedades que involucran la proliferacion celular. | |
| DE602005013244D1 (de) | Pharmazeutische zusammensetzungen für die kontroll | |
| BG108634A (en) | Injectable compositions for the controlled delivery of pharmacologically active compound | |
| BRPI0517719A (pt) | composição veterinária transmucosal compreendendo detomidina | |
| NZ587202A (en) | Methods for measuring a patient response upon administration of a drug and compositions thereof | |
| PT1299095E (pt) | Composicao anestesica aquosa limpida | |
| CY1114163T1 (el) | Μεθοδοι χρησεως ανταγωνιστων αγγειοπιεσινης με παραγοντες χημειοθεραπειας ανθρακυκλινης για να μειωνεται καρδιοτοξικοτητα ή/και να βελτιωνεται επιβιωση | |
| BRPI0817804A8 (pt) | Agente terapêutico para melhorar as propriedades da pele compreendendo um derivado de morfinano ou qualquer um de seus sais de adição de ácido farmacologicamente permissíveis como um ingrediente ativo | |
| HRP20100212T1 (hr) | Pripravci s povećanim elastificirajućim učinkom | |
| MX2022000843A (es) | Forma de dosificacion blanda masticable de uso veterinario. | |
| UA89795C2 (ru) | Фармацевтическая композиция, которая содержит эстер темозоломида | |
| UY30847A1 (es) | Uso de derivados de mononitrato de dianhidrohexita como agentes para el tratamiento de trastornos intestinales | |
| HRP20110085T1 (hr) | Fotostabilni farmaceutski pripravci za tretman herpesnog keratitisa koji sadrže brivudin | |
| BR0311642A (pt) | Formulação de divalproex de sódio de liberação aumentada | |
| MX2010003594A (es) | Formas cristalinas de sal sodica de dmxaa. | |
| WO2005025488A3 (en) | Methods for the controlled delivery of pharmacologically active compounds | |
| CO6270216A2 (es) | Formulaciones galenicas de alisquireno | |
| BRPI0508767A (pt) | composição que apresenta palatabilidade aprimorada, partìculas secas por congelamento peneiradas, partìculas secas por congelamento semelhantes a pó comprimìvel e de livre fluxo, processo para fabricar as mesmas, composições farmacêuticas com palatabilidade aprimorada, método para fabricar as mesmas e método para fabricar comprimidos |